Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate CancerStage IIB Prostate Cancer
Interventions
DRUG

Cholecalciferol

Given PO

DRUG

Genistein

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

OTHER

Placebo

Given PO

Trial Locations (11)

14642

University of Rochester, Rochester

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore

21287

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore

29572

Carolina Urologic Research Center, Myrtle Beach

35233

University of Alabama at Birmingham Cancer Center, Birmingham

53792

University of Wisconsin Hospital and Clinics, Madison

55417

Minneapolis Veterans Medical Center, Minneapolis

55455

University of Minnesota Medical Center-Fairview, Minneapolis

73104

University of Oklahoma Health Sciences Center, Oklahoma City

78229

Urology San Antonio Research PA, San Antonio

01805

Lahey Hospital and Medical Center, Burlington

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01325311 - Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer | Biotech Hunter | Biotech Hunter